Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al : mutations in TRNT1 result in a constitutive activation of type I interferon signalling - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue Annals of the Rheumatic Diseases Année : 2018

Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al : mutations in TRNT1 result in a constitutive activation of type I interferon signalling

Résumé

We read with great interest the paper of Giannelou et al1 reporting, for the first time, the efficacy of tumour necrosis factor (TNF) inhibitors in sideroblastic anaemia with immunodeficiency, fevers and developmental delay (SIFD). These authors also demonstrated high levels of interleukin (IL)-6, IL-12p40, IL-18, interferon (IFN)-γ and IFN-induced chemokines (IP-10 and MIG) in two patients. Herein, we wish to highlight that an activation of the type I IFN pathway may also be observed in SIFD [...]

Domaines

Immunologie
Fichier principal
Vignette du fichier
annrheumdis-2018-213745.full.pdf (125.31 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

pasteur-01819255 , version 1 (20-06-2018)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Marie-Louise Frémond, Isabelle Melki, Sven Kracker, Vincent Bondet, Darragh Duffy, et al.. Comment on: ‘Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors’ by Giannelou et al : mutations in TRNT1 result in a constitutive activation of type I interferon signalling. Annals of the Rheumatic Diseases, 2018, ⟨10.1136/annrheumdis-2018-213745⟩. ⟨pasteur-01819255⟩
45 Consultations
141 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More